Compare FATE & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FATE | EPSN |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.5M | 132.1M |
| IPO Year | 2013 | N/A |
| Metric | FATE | EPSN |
|---|---|---|
| Price | $1.06 | $4.74 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.92 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 110.2K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 5.11% |
| EPS Growth | N/A | ★ 11.33 |
| EPS | N/A | ★ 0.27 |
| Revenue | $7,137,000.00 | ★ $45,709,605.00 |
| Revenue This Year | N/A | $41.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.29 |
| Revenue Growth | N/A | ★ 46.76 |
| 52 Week Low | $0.66 | $4.36 |
| 52 Week High | $2.02 | $8.50 |
| Indicator | FATE | EPSN |
|---|---|---|
| Relative Strength Index (RSI) | 46.03 | 44.88 |
| Support Level | $1.03 | $4.76 |
| Resistance Level | $1.19 | $5.09 |
| Average True Range (ATR) | 0.08 | 0.18 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 36.71 | 14.44 |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.